Your results for

Filter by

Filter by
Results

Filter by

Content type
Key content topics
Key audience
Top cancer treatments

Moderately hypofractionated proton beam therapy for localized prostate cancer: 5-year outcomes of a phase II trial.

30/10/2024
/ Publications

This study from Japan included 100 patients with localized prostate cancer treated with moderately hypofractionated PT (70 GyRBE in 28 fractions) for evaluation...

Effectiveness and Safety of Carbon Ion Radiotherapy in Solid Tumors: A Systematic Review and Meta-Analysis.

30/10/2024
/ Publications

This systematic review and meta-analysis included 34 comparative studies and evaluated the effectiveness of carbon ion radiotherapy (CIRT) in patients with...

Prostate Advanced Radiation Technologies Investigating Quality of Life (PARTIQoL): Phase III Randomized Clinical Trial of Proton Therapy vs. IMRT for Localized Prostate Cancer.

05/11/2024
/ Publications

PARTIQoL is a multi-center phase 3 randomized trial comparing proton and photon for intermediate- or low-risk prostate cancer with a primary endpoint to compare...

Setting the Stage: Feasibility and Baseline Characteristics in the PARTIQoL Trial Comparing Proton Therapy Versus Intensity Modulated Radiation Therapy for Localized Prostate Cancer.

05/11/2024
/ Publications

Published in the Red Journal, this is a report from the PARTIQoL trial focusing on describing the trial design, patient baseline features, clinical details of...

Secondary Cancer in Prostate Cancer Patients Treated With Advanced External Beam Radiation Therapy.

05/11/2024
/ Publications

Using data of 133,898 N0M0 prostate cancer cases from the National Cancer Database, this study compared second primary cancer (SPC) probabilities among those...

Risk of radiation-induced second malignant neoplasms from photon and proton radiotherapy in paediatric abdominal neuroblastoma

08/07/2021
/ Publications
/
Secondary cancer

This study compared the carcinogenic risk associated with 3D-CRT, IMAT and PBS-PT)in the treatment of pediatric abdominal neuroblastoma. The risk of radiation...

Trends and variations in utilization and costs of radiotherapy for prostate cancer: A SEER medicare analysis from 2007 through 2016

08/02/2021
/ Publications
/
IMPT

Based on the SEER database, this study reported that for Medicare beneficiaries with a first-time diagnosis of prostate cancer, the utilization of IMRT, proton...

Cross-modality applicability of rectal normal tissue complication probability models from photon- to proton-based radiotherapy.

01/10/2019
/ Publications

This study aimed to assess the applicability of photon-based NTCP models to rectum morbidity outcomes following PT for prostate cancer patients. The data of...

Retrospective analysis of reduced energy switching and room switching times on throughput efficiency of a multi-room proton therapy center.

11/12/2019
/ Publications

A 4-room center treating ~90 patients/day, treating for ~7 years underwent a software upgrade which reduced room and energy switching times from ~30 to~20 sec...

Proton beam therapy delivered using pencil beam scanning vs. passive scattering/uniform scanning for localized prostate cancer: Comparative toxicity analysis of PCG 001-09.

11/08/2019
/ Publications
/
Pencil Beam Scanning - PBS
Toxicity

This study compared PBS toxicity rates with those of passive scattering/uniform scanning (PS/US) in a prospective multicenter registry. For low-to-intermediate...